News Home » Medical and Pharma » Roche's star MS medicine Ocrevus wins EU approval

Around the World

Roche's star MS medicine Ocrevus wins EU approval

James Bay 4 Jan 11
The European Union approved Roche's multiple sclerosis medicine Ocrevus, one the Swiss company's key new drugs that likely neared $1 billion in revenue in its first nine months on the U.S. market.